Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 5, 2003, Pages 905-910

  Philipp, Jana ^b   Dienst, Ariane ^b   Unruh, Maike ^b   Wagener, Anke ^b   Grunow, Andrea ^b   Engert, Andreas ^b   Fries, Jochen W U ^a   Gottstein, Claudia ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Laboratory for Tumor Therapy ^*

Author keywords

Coagulation; Lipopolysaccharides; Soluble tissue factor; Tumor endothelium; Vascular targeting

Indexed keywords

LIPOPOLYSACCHARIDE; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; THROMBOSIS; TREATMENT OUTCOME; TUMOR CELL;

ANIMALS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EMBOLIZATION, THERAPEUTIC; ENZYME ACTIVATION; FACTOR XA; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOMA, NON-HODGKIN; MICE; MICE, INBRED BALB C; MICE, SCID; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SOLUBILITY; SURFACE PLASMON RESONANCE; TERATOCARCINOMA; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037624943     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000067700.77438.3F     Document Type: Article

References (25)

1. Thorpe PE, Ran S. Tumor infarction by targeting tissue factor to tumor vasculature. Cancer J Sci Am. 2000;6(suppl 3):S237-S244.
2. Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost. 2001;86:66-74.
3. Rietschel ET, Kirikae T, Schade FU, Ulmer AJ, Holst O, Brade H, Schmidt G, Mamat U, Grimmecke H-D, Kusumoto S, Zaahringer U. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology. 1993;187:169-190.
4. Bannermann DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lib Invest. 1999;79:1181-1199.
5. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to lethal effects of endotoxin. Proc Natl Acad Sci U S A. 1979; 76:5939-5943.
6. Becker LJ, Rudbach JA. Potentiation of endotoxin toxicity by carrageenan. Infect Immun. 1978;19:1099-1100.
7. Pieroni RE, Broderick EJ, Bundeally A, Levine L. A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc Soc Exp Biol Med. 1970;133:790-794.
8. Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H, Gerdes J, Boie C. Establishment and characterization of four in vitro cell lines. J Cancer Res Clin Oncol. 1981;101:111-124.
9. Gottstein C, Wels W, Ober B, Thorpe PE. Generation and characterization of recombinant vascular targeting agents from hybridoma cell lines. Biotechniques. 2001;30:190-200.
10. Parr I, Wheeler E, Alexander P. Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA. Br J Cancer. 1973;27: 370-399.
11. Old LJ, Boyse EA. Current enigmas in cancer research. Harvey Lect. 1973;67:273-315.
12. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumor. Proc Natl Acad Sci U S A. 1975;72:3666-3670.
13. Nawroth P, Handley D, Matsueda G, De Waal R, Gerlach H, Blohm D, Stern D. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med. 1988;168:637-647.
14. Watanabe N, Niitsu Y, Umeno H, Kuriyama H, Neda H, Yamauchi N, Maeda M, Urushizaki I. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 1988;48:2179-2183.
15. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppression hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med. 1985;161:984-995.
16. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986;83: 4533-4537.
17. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böhrer H, Greten J, Martin E, Baeuerle PA, Waldherr R, Kisiel W, Ziegler R, Stern MD, Nawroth PP. Mechanism of the tumor necrosis factor α-mediated induction of endothelial tissue factor. J Biol Chem. 1995;270:26419-26432.
18. Parry GCN, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vase Biol. 1995;15:612-621.
19. Moll T, Czyz M, Holzmuller H, Hofer-Warbinek R, Wagner E, Bach FH, Hofer E. Regulation of the tissue factor promoter in endothelial cells: binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem. 1995;270:3849-3857.
20. Clauss M, Grell M, Fangmann C, Fiers W, Scheurich P, Risau W. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors. FEBS Lett. 1996;390:334-338.
21. Camera M, Giesen PLA, Fallon J, Aufiero BM, Taubman M, Tremoli E, Nemerson Y. Cooperation between VEGF and TNF-α is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:531-537.
22. Donate F, Kelly CR, Ruf W, Edgington TS. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X. Biochemistry. 2000;39:11467-11476.
23. Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function: analysis of a mutant with a selective deficiency in activity. J Biol Chem. 1992;267:14477-14482.
24. Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogencofactor complexes: implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem. 1993;268:21489-21492.
25. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002;62: 6132-6140.